Skip to main content
. 2022 May 24;26:151. doi: 10.1186/s13054-022-04016-x

Table 2.

Hazard ratios for mortality up to day 90

90-day mortality rate
Unadjusted Events, n (%) HR (95% CI)
 Erythromycin (n = 235) 76 (33.3%) 0.91 (0.69–1.19)
 Controls (n = 470) 167 (36.8%) 1.00 (ref)
PS matched
 Erythromycin (n = 211) 67 (32.8%) 0.89 (0.64–1.24)
 Controls (n = 211) 74 (36.6%) 1.00 (ref)
PS weighted Events, %
 Erythromycin 34.6% 0.95 (0.66–1.36)
 Controls 37.3% 1.00 (ref)

CI confidence interval, HR hazard ratio, IPTW inverse probability of treatment weighting, PS propensity score, ref referent